.jpg)
.jpg)
.jpg)
Friday, November 3, 2017
Monday, October 16, 2017
Monday, October 9, 2017
Monday, October 2, 2017
Wednesday, September 20, 2017
Tuesday, September 5, 2017
Tuesday, August 29, 2017
Monday, August 21, 2017
Tuesday, August 15, 2017
Thursday, August 10, 2017
Sunday, August 6, 2017
Monday, July 31, 2017
Wednesday, July 26, 2017
Monday, July 24, 2017
Monday, July 17, 2017
Wednesday, July 12, 2017
Monday, July 3, 2017
Thursday, June 22, 2017
Monday, June 12, 2017
Wednesday, June 7, 2017
Sunday, June 4, 2017
Sunday, May 28, 2017
Monday, May 22, 2017
Tuesday, May 9, 2017
Monday, May 8, 2017
Friday, April 28, 2017
Tuesday, April 18, 2017
Thursday, April 13, 2017
Monday, April 10, 2017
Thursday, April 6, 2017
Wednesday, April 5, 2017
Tuesday, March 28, 2017
Wednesday, March 22, 2017
Thursday, March 16, 2017
Wednesday, March 8, 2017
Wednesday, March 1, 2017
Monday, February 20, 2017
Wednesday, February 1, 2017
Sunday, January 29, 2017
Wednesday, January 25, 2017
Wednesday, January 18, 2017
Sunday, January 15, 2017
Tuesday, January 3, 2017
Models of In-Vivo Bacterial Infections for the Development of Antimicrobial Peptide-based Drugs
Models of In-Vivo Bacterial Infections for the Development of Antimicrobial Peptide-based Drugs
[ Vol. 17 , Issue. 5 ]
Author(s):
Jlenia Brunetti, Chiara Falciani, Luisa Bracci and Alessandro Pini Pages 613 - 619 ( 7 )
Abstract:
The increasing frequency of multi-resistant Gram-positive and Gram-negative bacteria and a long-term decreasing trend in the development of new antimicrobial molecules prompts research for new anti-infective agents with new modes of action.
Antimicrobial peptides (AMPs) are considered an interesting class of antibacterial molecules. Many new AMPs have been discovered and some are being evaluated for the development of new antibacterial therapeutics. Since the development of new antibacterial drugs has been neglected for decades, we are now faced with extreme medical need combined with a lack of technical experimental progress in setting up efficient models of antibacterial activity in animals. Here we review experiments with AMPs in animal models of sepsis, pneumonia and skin infection caused by bacteria. Animal models of infection have been of enormous predictive value in antibacterial drug discovery, both for elucidating AMP efficacy in the treatment of experimentally induced infection and for comparing the effectiveness of two or more antibiotics.
Keywords:
Antimicrobial peptides, In vivo models, Infection, Superbugs.
Affiliation:
Setlance srl, Department of Research and Development, Via Fiorentina 1, 53100 Siena, Italy.
Graphical Abstract:
Read Full-Text article
